The future of DNMTi in cancer therapy looks promising, particularly with the advancement of precision medicine. As we better understand the molecular mechanisms driving cancer, DNMTi can be more effectively targeted to specific patient populations. Ongoing clinical trials and research will continue to expand the therapeutic potential of DNMTi.
